TY - JOUR
T1 - Recurrent laryngeal nerve paralysis
T2 - Current concepts and treatment: Part I-phylogenesis and physiology
AU - Hartl, D. M.
AU - Brasnu, D. F.
PY - 2000/1/1
Y1 - 2000/1/1
N2 - The aim of this review article is to summarize current concepts in unilateral recurrent laryngeal nerve paralysis (URLNP). Important aspects of laryngeal phylogenesis, physiology, and anatomy are reviewed. Recent advances in the neurophysiology of URLNP are discussed. Revised and updated principles of diagnosis and treatment are provided. Glottic configuration and prognosis vary according to the type of neural lesion (neurapraxia, axonotmesis, or neurotmesis). Therapeutic indications depend on glottic configuration and prognosis. Treatment options include medialization thyroplasty, vocal fold augmentation by injection, arytenoid adduction, and laryngeal reinnervation. Each treatment option is summarized, and the results reported in the medical literature are reviewed.
AB - The aim of this review article is to summarize current concepts in unilateral recurrent laryngeal nerve paralysis (URLNP). Important aspects of laryngeal phylogenesis, physiology, and anatomy are reviewed. Recent advances in the neurophysiology of URLNP are discussed. Revised and updated principles of diagnosis and treatment are provided. Glottic configuration and prognosis vary according to the type of neural lesion (neurapraxia, axonotmesis, or neurotmesis). Therapeutic indications depend on glottic configuration and prognosis. Treatment options include medialization thyroplasty, vocal fold augmentation by injection, arytenoid adduction, and laryngeal reinnervation. Each treatment option is summarized, and the results reported in the medical literature are reviewed.
UR - http://www.scopus.com/inward/record.url?scp=0033645221&partnerID=8YFLogxK
U2 - 10.1177/014556130007901109
DO - 10.1177/014556130007901109
M3 - Review article
AN - SCOPUS:0033645221
SN - 0145-5613
VL - 79
SP - 858-876+879
JO - Ear, nose, & throat journal
JF - Ear, nose, & throat journal
IS - 11
ER -